Release Date: 08/12/22 09:35 Summary: Dean Vallve Appointed COO Price Sensitive: No Download Document 1.06MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%